Renal disease and HIV- Sanjay Pujari

APACC 2017

Cardiovascular disease and HIV- Somnuek Sungkanuparph

APACC 2017

Assessment of atherosclerotic cardiovascular disease (ASCVD) risks between HIV-infected patients receiving first-line and second-line antiretroviral therapy- Dr. J. Tiarukkitsagul

APACC 2017

Higher burden of chronic comorbidities among aged hospitalized HIV patients compared to non-HIV infected patients in Japan- Dr. D. Ruzicka

APACC 2017

Prevalence of sarcopenia and associated risk factors among HIV-infected individuals receiving suppressive antiretroviral therapy- Dr. R. Rajasuriar

APACC 2017

Recruiting people into HIV Services: eBooking- Panus Na Nakorn

APACC 2017

Online platforms to spur HIV testing- Joseph Tucker, MD, PhD, AM

APACC 2017

e-Cascade for real-time monitoring of HIV program- Matthew Avery

APACC 2017

Consideration regarding the service model on pre-exposure prophylaxis for men who have sex with men in the community- Dr. T.H. Kwan

APACC 2017

Pre-exposure prophylaxis uptake among men who have sex with men at a clinic in Bangkok, Thailand, 2016- Dr. W. Wimonsate

APACC 2017

Using a robust incentive-based, peer-centered model to identify new HIV cases among men who have sex with men, transgender women, and people who inject drugs in Cambodia- Dr. R. Sopha

APACC 2017

Population-based PrEP implementation in New South Wales, Australia- Andrew Grulich

APACC 2017

Round Table Discussion: True demand from the communities- Midnigh Poonkasetwattana

APACC 2017

Round Table Discussion: Genuine supply from the providers- Rossana Ditangco

APACC 2017

PrEP research and implementation gaps- Michael Cassell

APACC 2017

Access to treatment/care on the global level- Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhD

APACC 2017

Access to treatment/care on the country level- Giten Khwairakpam

APACC 2017

Barriers to access - Community perspective- Martin Choo, MMedSc

APACC 2017

New HIV drugs / regimens- Daniel Kuritzkes, MD

APACC 2017

New hepatitis drugs- Jürgen Rockstroh, MD

APACC 2017

Innovative ways to stimulate the demand of HIV and HCV testing- Philip Cunningham

APACC 2017

HIV-HCV Coinfection- Jürgen Rockstroch, MD

Asian Conference on Hepatitis and AIDS (ACHA) 2017

HIV-HCV Coinfection- Jürgen Rockstroch, MD

Asian Conference on Hepatitis and AIDS (ACHA) 2017

The Efficacy of antiviral therapy on the regression of liver fibrosis in CHB- Jidong Jia, MD, PhD

Asian Conference on Hepatitis and AIDS (ACHA) 2017